169 related articles for article (PubMed ID: 6702820)
1. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
Frey FJ; Frey BM
Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
[TBL] [Abstract][Full Text] [Related]
2. Altered prednisolone kinetics in patients with the nephrotic syndrome.
Frey FJ; Frey BM
Nephron; 1982; 32(1):45-8. PubMed ID: 7177276
[TBL] [Abstract][Full Text] [Related]
3. The effect of altered prednisolone kinetics in patients with the nephrotic syndrome and in women taking oral contraceptive steroids on human mixed lymphocyte cultures.
Frey BM; Frey FJ
J Clin Endocrinol Metab; 1985 Feb; 60(2):361-9. PubMed ID: 3155524
[TBL] [Abstract][Full Text] [Related]
4. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.
Shibasaki H; Nakayama H; Furuta T; Kasuya Y; Tsuchiya M; Soejima A; Yamada A; Nagasawa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):164-9. PubMed ID: 18387858
[TBL] [Abstract][Full Text] [Related]
6. Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism.
Frey FJ; Horber FF; Frey BM
Clin Pharmacol Ther; 1988 Nov; 44(5):510-21. PubMed ID: 2972434
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone.
Frey BM; Schaad HJ; Frey FJ
Eur J Clin Pharmacol; 1984; 26(4):505-11. PubMed ID: 6734709
[TBL] [Abstract][Full Text] [Related]
8. Prednisolone can increase glomerular permeability to proteins in nephrotic syndrome.
Wetzels JF; Sluiter HE; Hoitsma AJ; van Munster PJ; Koene RA
Kidney Int; 1988 Jun; 33(6):1169-74. PubMed ID: 3404815
[TBL] [Abstract][Full Text] [Related]
9. Prednisolone disposition and protein binding in oral contraceptive users.
Boekenoogen SJ; Szefler SJ; Jusko WJ
J Clin Endocrinol Metab; 1983 Apr; 56(4):702-9. PubMed ID: 6833459
[TBL] [Abstract][Full Text] [Related]
10. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
Frey FJ; Rüegsegger MK; Frey BM
Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission.
Gatti G; Perucca E; Frigo GM; Notarangelo LD; Barberis L; Martini A
Br J Clin Pharmacol; 1984 Apr; 17(4):423-31. PubMed ID: 6721988
[TBL] [Abstract][Full Text] [Related]
12. Nonlinear plasma protein binding and haemodialysis clearance of prednisolone.
Frey FJ; Gambertoglio JG; Frey BM; Benet LZ; Amend WJ
Eur J Clin Pharmacol; 1982; 23(1):65-74. PubMed ID: 6751835
[TBL] [Abstract][Full Text] [Related]
13. Endogenous and exogenous glucocorticoids in cushingoid patients.
Benet LZ; Frey FJ; Amend WJ; Lozada F; Frey BM
Drug Intell Clin Pharm; 1982 Nov; 16(11):863-8. PubMed ID: 6756849
[TBL] [Abstract][Full Text] [Related]
14. Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.
Szefler SJ; Ebling WF; Georgitis JW; Jusko WJ
Eur J Clin Pharmacol; 1986; 30(3):323-9. PubMed ID: 3732369
[TBL] [Abstract][Full Text] [Related]
15. Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy.
Wagner JG; Wexler D; Ağabeyoğlu IT; Bergstrom RF; Sakmar E; Kay DR
J Lab Clin Med; 1981 Apr; 97(4):487-501. PubMed ID: 7205057
[TBL] [Abstract][Full Text] [Related]
16. Dose dependent pharmacokinetics of prednisone and prednisolone in man.
Rose JQ; Yurchak AM; Jusko WJ
J Pharmacokinet Biopharm; 1981 Aug; 9(4):389-417. PubMed ID: 7310640
[TBL] [Abstract][Full Text] [Related]
17. Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome.
Reichert LJ; Koene RA; Wetzels JF
Nephrol Dial Transplant; 1999 Jan; 14(1):91-7. PubMed ID: 10052484
[TBL] [Abstract][Full Text] [Related]
18. Disposition and diuretic effect of furosemide in the nephrotic syndrome.
Keller E; Hoppe-Seyler G; Schollmeyer P
Clin Pharmacol Ther; 1982 Oct; 32(4):442-9. PubMed ID: 7116760
[TBL] [Abstract][Full Text] [Related]
19. The macromolecular binding of prednisone in plasma of healthy volunteers including pregnant women and oral contraceptive users.
Gustavson LE; Benet LZ
J Pharmacokinet Biopharm; 1985 Dec; 13(6):561-9. PubMed ID: 3834071
[TBL] [Abstract][Full Text] [Related]
20. Prednisolone disposition in steroid-dependent asthmatics.
Rose JQ; Nickelsen JA; Middleton E; Yurchak AM; Park BH; Jusko WJ
J Allergy Clin Immunol; 1980 Nov; 66(5):366-73. PubMed ID: 7440853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
